Chrysalis and VERDOT Announce Strategic Partnership to Expand Access to Advanced Purification Technologies for Emerging Biotech Companies
BURLINGTON, MA and SAINT BEAUZIRE, France — August 11, 2026 — Chrysalis Services, LLC and VERDOT today announced a strategic partnership designed to provide biotechnology and biopharma companies with streamlined access to advanced purification technologies within Chrysalis’ GMP ready infrastructure.
Through the partnership, VERDOT equipment will be hosted within Chrysalis facilities, creating a flexible access model that enables biotechnology companies to evaluate advanced chromatography and tangential flow filtration (TFF) technologies and access them for their development work, without the capital investment and operational burden of purchasing and maintaining equipment themselves.
Customers will have access to VERDOT’s single-use FlexiPro Chrom and FlexiPro TFF platforms, which are unique in their multi-scale flexibility and ability to support a broad range of development needs. They will also benefit from VERDOT’s InPlace chromatography columns, engineered to simplify the column packing process for demanding purification workflows.
The collaboration brings together VERDOT’s purification expertise and equipment portfolio with Chrysalis’ integrated infrastructure platform, enabling companies to accelerate development activities while preserving capital and maintaining operational flexibility. The model also allows customers to access optional technical guidance and support as they execute activities within the hosted environment.
How can our engineering expertise accelerate your innovation?
Reach out to learn more about how we can help you with your downstream processing needs.
